Epcoritamab,Lenalidomide,Rituximab
abbvie,genmab
['epcore,(-epcore nhl)', ' lena', 'nhl', 'epcoritamab', 'epcore,fl,1', 'mantle,(-dismantle)', 'lenalidomide', 'lymsm', 'lymphoma', ' epco ', 'follicular', 'emergent ']
#ash22 #lymsm #fl
falchi et al sc epcoritamab+ r2 in rr fl
mfu 6.4 mo epco 2y
r 6 mo
len 12 mo n=76, age 64 (30-79)
40% g3/4 neutropenia orr 95% cmr 80% high rr in high risk pts
pfs nr- too early to tell ph3 trial ongoing- epcore fl-1 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews